METHYL-PHENIDYLACETATE HYDROCHLORIDE (RITALIN) IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC PATIENTS
BLAINE CAREY M. D.1,
MARILYN WEBER R. N.2, , and
JACKSON A. SMITH M. D.3
1 Staff Physician, Norfolk State Hospital, Norfolk, Nebr.
2 Research Nurse, Norfolk State Hospital, Norfolk, Nebr.
3 Associate Director for Research, Nebraska Psychiatric Institute, Omaha, Nebr.
In this group of 50 chronic schizophrenic patients, half of whom received Ritalin and half an identical appearing placebo the Ritalin was without demonstrable effect. Six of those on Ritalin showed a decrease in appetite, abdominal discomfort, and weight loss during the test.
